Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 1-year average of 31.91%, near the low end of its 1-year range (0.00%–100.00%).
100.00% below its 12-month average of 31.91%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
31.91%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
22.47%
GROSS MARGIN AVG 20Y
21.19%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 673 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Cocrystal Pharma, Inc.
Market Cap
$15.58M
Gross Margin
0.00%
TTM Avg
31.91%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$15.75M
Gross Margin
107.54%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
16.67%
Market Cap
$15.04M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-2.45%
Market Cap
$15.03M
Gross Margin
95.88%
TTM Avg
95.90%
3Y Avg
96.27%
5Y Avg
96.83%
Market Cap
$16.15M
Gross Margin
0.00%
TTM Avg
-3731.89%
3Y Avg
-2384.22%
5Y Avg
-1567.12%
Market Cap
$16.58M
Gross Margin
-88.25%
TTM Avg
-11.22%
3Y Avg
9.24%
5Y Avg
11.19%
Market Cap
$16.58M
Gross Margin
21.95%
TTM Avg
11.59%
3Y Avg
17.76%
5Y Avg
20.87%
Market Cap
$14.24M
Gross Margin
84.15%
TTM Avg
52.79%
3Y Avg
35.70%
5Y Avg
25.98%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | $15.58M | 0.00% | 31.91% | 0.00% | 0.00% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | 107.54% | 50.00% | 25.00% | 16.67% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | 0.00% | 0.00% | 0.00% | -2.45% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.03M | 95.88% | 95.90% | 96.27% | 96.83% |
| BioCardia, Inc. (BCDA)vs › | $16.15M | 0.00% | -3731.89% | -2384.22% | -1567.12% |
| Dyadic International, Inc. (DYAI)vs › | $16.58M | -88.25% | -11.22% | 9.24% | 11.19% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | 21.95% | 11.59% | 17.76% | 20.87% |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.44M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.24M | 84.15% | 52.79% | 35.70% | 25.98% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.09M | 0.00% | -52.16% | -139.89% | -776.52% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 59.56% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -36.86% |
| 2020-09-30 | -324.74% |
| 2020-06-30 | -256.68% |
| 2020-03-31 | 99.72% |
| 2019-12-31 | -138.31% |
| 2019-09-30 | 99.78% |
| 2019-06-30 | 99.82% |
| 2019-03-31 | 99.98% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 153.22% |
| 2015-09-30 | 90.93% |
| 2015-06-30 | 92.79% |
| 2015-03-31 | 94.22% |
| 2014-12-31 | 85.01% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 166.24% |
| 2013-09-30 | 53.18% |
| 2013-06-30 | 28.21% |
| 2013-03-31 | 29.18% |
| 2012-12-31 | 44.48% |
| 2012-09-30 | 41.33% |
| 2012-06-30 | 41.34% |
| 2012-03-31 | 49.20% |
| 2011-12-31 | -8.29% |
| 2011-09-30 | 45.43% |
| 2011-06-30 | 49.11% |
| 2011-03-31 | 46.40% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 99.99% |
| 2010-06-30 | 99.96% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
